While insiders own 25% of Recce Pharmaceuticals Ltd (ASX:RCE), retail investors are its largest shareholders with 55% ownership

Key Insights The considerable ownership by retail investors in Recce Pharmaceuticals indicates that they collectively...

Read Full Article →